Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia
Authors:
Open Access
- 10 May 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 907490
Abstract
Vascular smooth muscle cell (VSMC) phenotypic transformation, proliferation, and migration play a pivotal role in developing neointimal hyperplasia after vascular injury, including percutaneous transluminal angioplasty and other cardiovascular interventions. Anemoside B4 (B4) is a unique saponin identified from the Pulsatilla chinensis (Bge.) Regel, which has known anti-inflammatory activities. However, its role in modulating VSMC functions and neointima formation has not been evaluated. Herein, we demonstrate that B4 administration had a potent therapeutic effect in reducing neointima formation in a preclinical mouse femoral artery endothelium denudation model. Bromodeoxyuridine incorporation study showed that B4 attenuated neointimal VSMC proliferationin vivo. Consistent with thein vivofindings, B4 attenuated PDGF-BB-induced mouse VSMC proliferation and migrationin vitro. Moreover, quantitative RT-PCR and Western blot analysis demonstrated that B4 suppressed PDGF-BB-induced reduction of SM22α, SMA, and Calponin, suggesting that B4 inhibited the transformation of VSMCs from contractile to the synthetic phenotype. Mechanistically, our data showed B4 dose-dependently inhibited the activation of the phosphatidylinositol 3-kinase (PI3K)/AKT and p38 mitogen-activated protein kinase MAPK signaling pathways. Subsequently, we determined that B4 attenuated VSMC proliferation and migration in a p38 MAPK and AKT dependent manner using pharmacological inhibitors. Taken together, this study identified, for the first time, Anemoside B4 as a potential therapeutic agent in regulating VSMC plasticity and combating restenosis after the vascular intervention.Keywords
Funding Information
- National Institutes of Health
- American Heart Association
This publication has 56 references indexed in Scilit:
- Smooth muscle cell phenotypic switching in atherosclerosisCardiovascular Research, 2012
- Akt signalling in health and diseaseCellular Signalling, 2011
- Vascular Smooth Muscle Cell Proliferation in RestenosisCirculation: Cardiovascular Interventions, 2011
- Phosphoinositide 3-kinase signalling in the vascular systemCardiovascular Research, 2008
- Requirement for p38 Mitogen-Activated Protein Kinase Activity in Neointima Formation After Vascular InjuryCirculation, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesisGenes & Development, 2006
- Modification of PI3K- and MAPK-Dependent Chemotaxis in Aortic Vascular Smooth Muscle Cells by Protein Kinase C βIICirculation Research, 2005
- A Transforming Growth Factor-β Control Element Required for SM α-Actin Expression in Vivo Also Partially Mediates GKLF-dependent Transcriptional RepressionJournal of Biological Chemistry, 2003
- Platelet‐derived growth factor regulates actin isoform expression and growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cellsJournal of Cellular Physiology, 1990